Our goal for many years has been “zero accidents” on site.
This is reflected in a variety of measures, including awareness-raising, training and the development of a sense of responsibility, decision trees and internal audits, etc.As a result, at the end of March 2011, we had had no lost-time injuries for eight years and we aim to continue in the same vein.
Reducing potential risks related to our processes is a constant concern and processes are assessed from a safety point of view using the Preliminary Risk Analysis method, and the HAZOP method for the most potentially hazardous processes.
Environment
In addition, having been ISO 14001 certified since June 2000, we have an environmental policy that takes into account protection of the environment at each stage of a product’s life cycle, with a view to:
-
reducing raw material consumption,
-
minimizing waste,
-
replacing hazardous products whenever possible.
We also have an industrial effluent treatment plant capable of processing around 120 m3 per day. Waste is then forwarded to the municipal wastewater treatment plant for final purification.
Quality
Our Quality policy aims to maintain our standards in terms Good Manufacturing Practices (French GMP/c.GMP) in order to guarantee maximum product quality for our customers.
Our site has been inspected and approved by the FDA since 1986 and by the French Agency for the Safety of Healthcare Products (AFSSAPS) since 2005. Our frame of reference is ICH Q7.
The most recent FDA inspection took place from September 13 to 17, 2010, leading to a favorable opinion by the FDA.